Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-02-27
1999-03-23
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142315, 5142312, 5142288, 514360, 514361, 514374, 514378, 540543, 540602, 540612, 544 70, 544153, 544158, 544171, 544172, 544143, 544146, 548124, 548125, 548131, 548143, 548215, 548240, C07D22314, C07D41300, A61K 3155, A61K 31535
Patent
active
058859845
ABSTRACT:
Aminocyclohexylester compounds, including thioesters, are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the blockade of ion channels and the treatment of arrhythmias.
REFERENCES:
patent: 2954380 (1960-09-01), Shapiro
patent: 4438130 (1984-03-01), Kaplan
patent: 4656182 (1987-04-01), Horwell
patent: 4737493 (1988-04-01), Horwell
patent: 4855316 (1989-08-01), Horwell et al.
Abraham et al., "Antiarrhythmic Properties of Tetrodotoxin Against Occlusion-Induced Arrhythmias in the Rat: A Novel Approach to the Study of the Antiarrhythmic Effects of Ventricular Sodium Channel Blockade," J. Pharmacol. Exp. Ther. 251(3):1166-1173, 1989.
Curtis and Walker, "Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia," Cardiovasc. Res. 22:656-665, 1988.
Hall, Jr. et al., "Aminomercuration of Olefins," Journal of Organic Chemistry 37(20):3069-3075, 1972.
Penz et al., "A New ECG Measure (RSh) for Detecting Possible Sodium Channel Blockade in Vivo in Rats," J. Pharmacol. Methods 27(1):51-58, 1992.
Pugsley et al., "Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion," Eur. J. Pharmacol. 212:15-19, 1992.
Pugsley et al., "Cardiovascular actions of the .kappa.-agonist, U-50,488H, in the absence and presence of opioid receptor blockade," Br. J. Pharmacol. 105:521-526, 1992.
Pugsley et al., "Electrophysiological and antiarrhythmic actions of the .kappa. agonist PD 129290, and its R,R (+)-enantiomer, PD 129289," Br. J. Pharmacol. 110:1579-1585, 1993.
Pugsley et al., "Cardiovascular Actions of U50,488H and Related Kappa Agonists," Cardiovascular Drug Reviews 11(2):151-164, 1993.
Shapiro et al., "Aminocyclohexyl Esters," Journal of the American Chemical Society 81:3993-3996, 1959.
Laboratori Farmaceutici A. Malizia S.p.A., "Esters of 4-piperidinocyclohexanol," Chemical Abstracts 63: 1773b, 1965.
Laboratori Farmaceutici A. Malizia S.p.A., "Piperidine-n-cyclohexanol esters," Derwent Abstract No. 66-16021F, 1966.
MacLeod Bernard A.
Walker Michael J. A.
Wall Richard A.
Kifle Bruck
Shah Mukund J.
University of British Columbia
LandOfFree
Aminocyclohexylesters and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminocyclohexylesters and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminocyclohexylesters and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2125577